A new study led by Cardiff University has shed light on how the COVID-19 virus "interferes" with the body's initial immune response to avoid detection.
Jul 19, 2022
0
57
A new study from MIT suggests that the dozens of mutations in the spike protein of the omicron variant help it to evade all four of the classes of antibodies that can target the SARS-CoV-2 virus that causes COVID-19.
Feb 1, 2022
0
182
In a recurring pattern of evolution, SARS-CoV-2 evades immune responses by selectively deleting small bits of its genetic sequence, according to new research from the University of Pittsburgh School of Medicine.
Feb 3, 2021
0
204
More than two years into the COVID-19 pandemic, people are realizing that the "new normal" will probably involve learning to co-exist with SARS-CoV-2. Some treatments are available, but with new variants emerging, researchers ...
Jun 29, 2022
0
122
Though underlying medical conditions play an important role, many aspects of why COVID-19 severity can differ vastly from one patient to another have remained unclear.
May 19, 2022
0
121
The Swiss medicines agency Swissmedic on Friday approved the vaccination of children aged between five and 11 with Pfizer-Biontech's Comirnaty vaccine.
Dec 11, 2021
0
25
While most people survive and recover from COVID, for some people symptoms can persist for months or years. When symptoms last longer than 12 weeks, the condition is known as long COVID.
Jun 9, 2023
0
8
As COVID-19 sweeps the world, related viruses quietly circulate among wild animals. A new study shows how SARS-CoV-2, the virus that causes COVID-19, and SARS-CoV-1, which caused the 2003 SARS outbreak, are related to each ...
Feb 25, 2021
0
17
From mRNA vaccines entering clinical trials, to peptide-based vaccines and using molecular farming to scale vaccine production, the COVID-19 pandemic is pushing new and emerging nanotechnologies into the frontlines and the ...
Jul 15, 2020
0
11
Alterations in the biochemical makeup of bulk plasma IgG, or Fc glycosylation, can predict COVID-19 disease severity and vaccine antibody response, according to a recent study by researchers at RUSH University and Northwestern. ...
Feb 10, 2023
0
103
